Prices delayed by at least 15 minutes | Print
Synairgen PLC (SNG)
ORD 1POpen
5.72p
Previous close
5.76p
Trade high
7.5p
Volume
1,363,988
Year high
11.00p
Year low
4.00p
Dividend yield
-
Market capitalisation
£14.10 mn
P/E ratio
-
ISIN
GB00B0381Z20
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, SG018, and others.
News
Recent trades
Date | Time | Price | Quantity | Value (£) |
---|---|---|---|---|
17/05/2024 | 04:35:00 | 7 | 694 | 48.58 |
17/05/2024 | 04:29:47 | 6.811 | 14,046 | 956.67 |
17/05/2024 | 04:29:22 | 6.811 | 7,288 | 496.39 |
17/05/2024 | 04:22:52 | 6.811 | 5,000 | 340.55 |
17/05/2024 | 04:20:47 | 7.323 | 2,300 | 168.43 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.